To ensure fair representation of women in clinical trials, regulatory bodies should establish mandatory quota systems. These quotas would set minimum thresholds for women's participation, reflecting their proportion in the general population or among those affected by the condition being studied. This approach ensures that women's health outcomes are accurately represented and researched.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.